| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-06 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.23 | 5e-06 |